Citruslabs
Santa Monica, California, 90404, United States
NCT Number: NCT06283732
The study aims to evaluate the effectiveness of a dietary supplement (greens powder), on improving digestive health, quality of life, energy levels, and satiety over a 14-day period. Participants, aged 18-65 and experiencing mild digestive issues, will consume the greens powder daily and report outcomes through diaries and questionnaires.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Santa Monica, California, 90404, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants are to consume one scoop (8.5 g) of the greens powder mixed in 8-10 oz of water every morning before breakfast for two weeks.
Time frame: 14 days from the start of intervention
Measure the change in digestive health using daily diaries and the Bristol Stool Scale (BSS).
Time frame: 14 days from the start of intervention
Assess improvements in participants' quality of life, energy levels, satiety, and overall well-being through validated questionnaires.
Amway Corp
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05253287
Atrophy, Digestive System Disease
Chandigarh, Uttarakhand, India
View Trial DetailsNCT03037385
Adenocarcinoma, Adenocarcinoma, Papillary
Phoenix, Arizona, United States
View Trial DetailsNCT03646292
Diabetes Mellitus, Diabetes Mellitus, Type 2
Seoul, South Korea
View Trial DetailsNCT03535727
Adenocarcinoma, Carcinoma
Baltimore, Maryland, United States
View Trial Details